Net sales grew 4.6% year-over-year to ¥259.7 billion, with strong medical and cosmetic sales, but operating profit declined 1.0% and net profit fell 2.7%. Full-year guidance remains unchanged, projecting modest growth.
Original document:
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.